Actym Therapeutics Raises $34 Million Series A

Financing will fund Actym's cancer immunotherapy pipeline into clinical development BERKELEY, Calif., April 27, 2020 -- (Healthcare Sales & Marketing Network) -- Actym Therapeutics, a privately-held immuno-oncology company, announced today the completi... Biopharmaceuticals, Oncology, Venture Capital, Personnel Actym Therapeutics, S. Typhimurium Attenuated Cancer Therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news